Hrt Financial LP Fibrogen Inc Transaction History

Hrt Financial LP

$15.7 Billion
Q4 2024

A detailed history of Hrt Financial LP transactions in Fibrogen Inc stock. As of the latest transaction made, Hrt Financial LP holds 24,084 shares of FGEN stock, worth $18,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,084

Holding current value

$18,544

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.3 - $0.58 $7,225 - $13,968	24,084 New	24,084 $12,000
Q2 2024 Aug 12, 2024	BUY	$0.89 - $2.36 $159,422 - $422,737	179,126 New	179,126 $159,000
Q4 2023 Feb 09, 2024	BUY	$0.38 - $0.91 $104,578 - $250,438	275,207 Added 341.6%	355,770 $315,000
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $63,644 - $227,993	80,563 New	80,563 $69,000
Q1 2023 May 12, 2023	BUY	$15.95 - $25.18 $3.08 Million - $4.86 Million	193,099 New	193,099 $3.6 Million
Q2 2022 Aug 12, 2022	BUY	$7.94 - $12.96 $128,310 - $209,433	16,160 Added 36.56%	60,356 $637,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $498,986 - $697,003	-41,513 Reduced 48.43%	44,196 $531,000
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $851,090 - $1.32 Million	85,709 New	85,709 $1.21 Million
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $433,460 - $602,432	-12,535 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $463,544 - $607,320	12,535 New	12,535 $463,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

37.4M

Call Options Held

351K

Put Options Held

105K

Armistice Capital, LLC New York, NY

6.8M
Shares

$5.24 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$4.53 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

4.62M
Shares

$3.55 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$3.01 Million
0.01% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$1.86 Million
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $72.2M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account